Moghrabi, Albert <br/><br/>
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.  [electronic resource] 

 -  Blood  Feb 2007 
 - 896-904 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2006-06-027714  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Asparaginase--therapeutic use<br/>Cardiotonic Agents--therapeutic use<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cranial Irradiation<br/>Disease-Free Survival<br/>Doxorubicin--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant<br/>Male<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Razoxane--therapeutic use<br/>Treatment Outcome